NCT04641000 (BLOOM-LTFU) is a clinical trial in Infant, Premature, Diseases, sponsored by University of Calgary.

Who is sponsoring NCT04641000?

NCT04641000 is sponsored by University of Calgary.

What condition does NCT04641000 study?

NCT04641000 studies Infant, Premature, Diseases, Infant, Asthma, Asthma in Children, Allergies, Infant, Extremely Premature.

Is NCT04641000 still recruiting?

NCT04641000 is currently terminated. Last updated 7 April 2022.

Last reviewed 2022-04-07 · How we verify

NCT04641000: BLOOM-LTFU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Alberta BLOOM Long Term Follow Up Study

Terminated Last updated 7 April 2022

What this trial tests

trial in Infant, Premature, Diseases in 15 participants. Terminated before completion.

Timeline

20 November 2020

Primary endpoint
16 August 2021

26 March 2022

Quick facts

Lead sponsor	University of Calgary
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	15
Start date	20 November 2020
Primary completion	16 August 2021
Estimated completion	26 March 2022
Sites	1 location across Canada

Conditions studied

Infant, Premature, Diseases — all drugs for Infant, Premature, Diseases →
Infant — all drugs for Infant →
Asthma — all drugs for Asthma →
Asthma in Children — all drugs for Asthma in Children →

Sponsor

University of Calgary

Who can join

Adults 1 to 2, any sex, with Infant, Premature, Diseases or Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, observational clinical cohort study involving children born very preterm at less than 31 weeks and six days gestation. The purpose of this study is to investigate the microbiome (the collection of microbes in a biological site) alternations resulting from preterm birth and associations with the risk of immune dysregulation, asthma and allergies.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Microbiota in Children and Adolescents with Asthma.
Casali L, Stella GM. · · 2024 · cited 2× · PMID 39457140 · DOI 10.3390/children11101175
The BLOOM Study: Protocol for a prospective, observational cohort study exploring the early-life microbiomes of preterm infants and their childhood health outcomes
Asbury MR, Guedez A, Lee J, Mercer EM, et al · · 2026 · DOI 10.21203/rs.3.rs-7330498/v1

Verify or expand the search:

Other recruiting trials for Infant, Premature, Diseases

Currently open trials in the same condition.

NCT07216664 — Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants · NA · recruiting
NCT06613477 — PK/PD of Digoxin in Infants With SVHD · Phase 1, PHASE2 · recruiting
NCT05942924 — The NEU-STIM Trial · NA · recruiting
NCT06366893 — Enteral Supplementation With Docosahexaenoic Acid and Arachidonic Acid (DHA-AA) in Preterm Infants · NA · recruiting

Other University of Calgary trials

Trials by the same sponsor.

NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04641000 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Calgary
Last refreshed: 7 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04641000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing